Polymorphic characterization of pharmaceutical solids, donepezil hydrochloride, by 13C CP/MAS solid-state nuclear magnetic resonance spectroscopy

Bulletin of the Korean Chemical Society

Volumn 30, Issue 9, 2009, Pages 2007-2010

  Park, Tae Joon ^a   Ko, Dong Hyun ^b   Kim, Young Ju ^b   Kim, Yongae ^a  

^a Hankuk University of Foreign Studies   (South Korea)

^b CJ Corporation   (South Korea)

Author keywords

CP MAS; Donepezil; Pharmaceutical solids; Polymorphism; Solid state NMR

Indexed keywords

ACETYLCHOLINESTERASE; ALZHEIMER'S DISEASE; COGNITIVE PERFORMANCE; CP/MAS; CRYSTALLINE FORM; DONEPEZIL; FOURIER TRANSFORM INFRARED; PHARMACEUTICAL MATERIALS; POLYMORPHIC FORMS; PROCESSABILITY; SOLID STATE NMR; SOLID STATE NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SOLID-STATE NMR SPECTROSCOPY; STRUCTURAL INFORMATION;

BIOCHEMISTRY; DRUG PRODUCTS; HYDRATES; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE; POLYMORPHISM; RESONANCE; SOLID STATE PHYSICS; X RAY POWDER DIFFRACTION;

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

EID: 75649123778     PISSN: 02532964     EISSN: 12295949     Source Type: Journal    
DOI: 10.5012/bkcs.2009.30.9.2007     Document Type: Article

References (24)

1. Byrn, S.; Pfeiffer, R.; Ganey, M.; Hoiberg, C.; Poochikian, G. Pharm. Res. 1995, 12, 945.
2. Saindon, P.J.; Cauchon, N.S.; Sutton, P.A.; Chang, C.J.; Peck, G.E.; Byrn, S.R. Pahrm. Res. 1993, 10, 197.
3. Geppi, M.; Mollica, G.; Borsacchi, S.; Veracini, C.A. Applied Spectroscopy Reviews 2008, 43, 202.
4. Kim, Y.A.; Kim, A.R. Bull. Korean Chem. Soc. 2002, 23, 1729.
5. Katsuhiko, M.; Sachio, T.; Hiroyuki, K.; Yasuyuki, S.; Tetsuo, H.; Etsuo, Y.; Katsuhide, T. Int. J. Pharm. 2006, 318, 146.
6. Park, J.S.; Kang, H.W.; Park, S.J.; Kim, C.K. Eur. J. Pharm. Biopharm. 2005, 60, 407.
7. Lubach, J. W; Padden, B.E.; Winslow, S.L.; Salsbury, J.S.; Masters, D.B.; Topp, E.M.; Munson, E.J. Anal. Bioanal. Chem. 2004, 378, 1504.
8. Haleblian, J.; McCrone, W. J. Pharm. Sci. 1969, 58, 911.
9. Fukuoka, E.; Makita, M.; Yamamura, S. Chem. Pharm. Bull. 1986, 34, 4314.
10. Law, S.L.; Lo, W.Y.; Lin, F.M.; Chaing, C.H. Int. J. Pharm. 1992, 84, 161.
11. Fukuoka, E.; Makita, M.; Yamamura, S. Chem. Pharm. Bull. 1989, 37, 1047.
12. Monkhouse, D.C.; Van, C.L. Drug. Dev. Indust. Pharm. 1984, 10, 1175.
13. Bugay, D.E. Pharm. Res. 1993, 10, 317.
14. Brittain, H.G. J. Pharm. Sci. 1997, 86, 405.
15. Shintani, E.Y.; Uchida, K.M. Am. J. Health-Syst. Pharm. 1997, 54, 2805.
16. Rho, J.P.; Lipson, L.G. Formulary 1997, 32, 677.
17. Bryson, H.M.; Benfield, P. Drugs & Aging 1997, 19, 234.
18. Elati, C.R.; Vankawala, P.J. Indian J. Chem. 2005, 44B, 1231.
19. Vrbinc, M.; Jordan-Kotar, B.; Smrkolj, M.; Vrecer, F. Acta Chim. Slov. 2007, 54, 254.
20. Hartmann, S.R.; Hahn, E.L. Phys. Rev. 1962, 128, 2043.
21. Dixon, W.T.; Schaefer, J.; Sefcik, M.D.; Stejskal, E.O.; McKay, R.A. J. Magn. Reson. 1982, 49, 341.
22. Park, T.J.; Kim, J.; Kim, T.K.; Park, H.M.; Choi, S.S.; Kim, Y. Bull. Kor. Chem. Soc. 2008, 29, 2459.
23. Park, T.J.; Choi, S.S.; Kim, Y. Bull. Kor. Chem. Soc. 2009, 30, 149.
24. Bennett, A.E.; Rienstra, C.M.; Auger, M.; Lakshmi, K.V.; Griffin, R.G. J. Chem. Phys. 1995, 103, 6951.